Clinical Trial Update: The Neoadjuvant Treatment of Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma. [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating neoadjuvant treatment for locally advanced thoracic esophageal squamous cell carcinoma using camrelizumab in combination with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma
• Thoracic Esophageal Cancer

Drugs mentioned

• Camrelizumab (camrelizumab)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Efficacy and Safty of Camrelizumab Plus S-1 Maintenance After First-line Induction Chemotherapy for GC | Phase 2 | Status: UNKNOWN